Header Logo

Annabelle Santos Volgman

Concepts (370)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
132
7.910
Why?
Cardiovascular Diseases
22
2024
333
5.730
Why?
Stroke
21
2023
254
4.510
Why?
Heart Failure
8
2023
167
2.630
Why?
Female
79
2024
14411
2.190
Why?
Humans
104
2024
26049
2.090
Why?
Transcatheter Aortic Valve Replacement
4
2023
20
2.030
Why?
Aortic Valve Stenosis
4
2023
21
2.030
Why?
Anticoagulants
7
2022
86
1.970
Why?
Myocardial Infarction
11
2023
134
1.840
Why?
Risk Factors
32
2024
2246
1.780
Why?
Healthcare Disparities
6
2020
81
1.730
Why?
Coronary Artery Disease
8
2022
127
1.710
Why?
Sex Factors
18
2022
442
1.650
Why?
Pregnancy Complications, Cardiovascular
6
2023
15
1.580
Why?
Hospital Mortality
8
2023
130
1.560
Why?
Cardiologists
2
2023
7
1.540
Why?
Exercise
7
2022
450
1.430
Why?
Cardiology
5
2022
43
1.430
Why?
Cognitive Dysfunction
6
2024
1026
1.380
Why?
Risk Assessment
14
2022
622
1.370
Why?
Sex Characteristics
7
2023
118
1.300
Why?
Hospitalization
8
2021
294
1.290
Why?
Life Style
8
2020
187
1.260
Why?
Women's Health
4
2020
178
1.260
Why?
Myocardial Ischemia
4
2022
41
1.250
Why?
Male
48
2023
14025
1.230
Why?
Aged
41
2024
8719
1.220
Why?
Primary Prevention
4
2022
30
1.180
Why?
Quality of Life
8
2023
609
1.180
Why?
Acute Kidney Injury
3
2023
40
1.170
Why?
United States
27
2023
1981
1.160
Why?
Cardiovascular System
3
2022
15
1.160
Why?
Physicians, Women
3
2022
17
1.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
43
1.110
Why?
Pacemaker, Artificial
3
2023
22
1.060
Why?
Arrhythmias, Cardiac
6
2019
68
1.030
Why?
Catheter Ablation
3
2022
65
1.020
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
24
0.980
Why?
Adrenergic beta-Antagonists
2
2020
27
0.980
Why?
Middle Aged
33
2024
8511
0.970
Why?
Health Status Disparities
4
2019
72
0.960
Why?
Defibrillators, Implantable
3
2021
12
0.950
Why?
Anti-Arrhythmia Agents
7
2022
32
0.940
Why?
American Heart Association
4
2023
18
0.890
Why?
Ischemic Attack, Transient
2
2023
18
0.880
Why?
Terminal Care
1
2023
26
0.830
Why?
Echocardiography, Doppler, Color
2
2019
13
0.820
Why?
Heart Defects, Congenital
1
2023
23
0.820
Why?
Myocarditis
1
2022
9
0.810
Why?
Premature Birth
1
2022
11
0.800
Why?
Electrocardiography
7
2015
104
0.780
Why?
Pregnancy
9
2023
310
0.770
Why?
Breast Neoplasms
3
2021
353
0.770
Why?
Coronavirus
1
2021
2
0.750
Why?
Length of Stay
4
2020
302
0.740
Why?
Chest Pain
1
2020
19
0.700
Why?
Brain Ischemia
1
2021
60
0.700
Why?
Intersectoral Collaboration
1
2020
7
0.700
Why?
Endothelium
1
2020
11
0.690
Why?
Social Media
1
2021
36
0.690
Why?
Treatment Outcome
14
2023
3293
0.680
Why?
Vascular Diseases
1
2020
43
0.670
Why?
Patient Care Management
2
2021
19
0.670
Why?
Takotsubo Cardiomyopathy
1
2019
12
0.670
Why?
Ambulatory Care Facilities
2
2022
35
0.660
Why?
Myxoma
1
2019
4
0.650
Why?
Cognition
4
2024
1301
0.650
Why?
Heart Neoplasms
1
2019
8
0.650
Why?
Cardiomyopathies
1
2019
32
0.650
Why?
Comorbidity
5
2021
466
0.650
Why?
Heart Diseases
1
2020
56
0.640
Why?
Hypertension
7
2023
217
0.640
Why?
Betacoronavirus
1
2020
70
0.640
Why?
Age Factors
8
2021
744
0.640
Why?
Heart Failure, Diastolic
1
2018
2
0.630
Why?
Prevalence
6
2020
433
0.630
Why?
Women's Health Services
1
2018
9
0.620
Why?
Heart Ventricles
1
2019
86
0.620
Why?
Coronavirus Infections
1
2020
82
0.610
Why?
Pneumonia, Viral
1
2020
85
0.610
Why?
Culturally Competent Care
1
2018
11
0.610
Why?
Delivery of Health Care, Integrated
1
2018
23
0.610
Why?
Warfarin
3
2016
26
0.610
Why?
Emigrants and Immigrants
1
2018
19
0.600
Why?
Antineoplastic Agents
1
2020
176
0.600
Why?
Atherosclerosis
1
2018
50
0.580
Why?
Prognosis
7
2021
750
0.530
Why?
Lipoprotein(a)
1
2016
3
0.530
Why?
Dyslipidemias
1
2016
16
0.510
Why?
Biomarkers
5
2024
551
0.510
Why?
Health Knowledge, Attitudes, Practice
2
2022
166
0.500
Why?
Diabetes Mellitus
3
2022
126
0.500
Why?
Electrodes
1
2015
11
0.500
Why?
Secondary Prevention
3
2022
52
0.480
Why?
Cost of Illness
1
2015
46
0.480
Why?
Social Support
1
2016
182
0.480
Why?
Adult
15
2023
7367
0.470
Why?
Magnetic Resonance Imaging
1
2019
1140
0.450
Why?
Aged, 80 and over
9
2021
4674
0.450
Why?
Electric Countershock
6
2020
10
0.450
Why?
Patient Readmission
3
2019
130
0.440
Why?
Aspirin
2
2020
78
0.440
Why?
Aortic Valve
3
2023
21
0.440
Why?
Retrospective Studies
10
2022
3305
0.420
Why?
Non-ST Elevated Myocardial Infarction
3
2022
3
0.420
Why?
ST Elevation Myocardial Infarction
3
2022
9
0.410
Why?
Cross-Sectional Studies
6
2024
853
0.390
Why?
Atrial Appendage
2
2022
36
0.390
Why?
Coronary Angiography
3
2020
68
0.380
Why?
Patient Acceptance of Health Care
1
2012
74
0.380
Why?
Alzheimer Disease
1
2023
2075
0.360
Why?
Frailty
2
2022
35
0.350
Why?
Cardiac Resynchronization Therapy Devices
2
2019
5
0.340
Why?
Cardiovascular Agents
2
2021
25
0.340
Why?
Feasibility Studies
2
2020
202
0.330
Why?
Hospital Costs
2
2020
63
0.330
Why?
Practice Guidelines as Topic
3
2021
291
0.310
Why?
Heart Atria
2
2019
23
0.300
Why?
Ventricular Fibrillation
2
2021
14
0.290
Why?
Percutaneous Coronary Intervention
3
2022
24
0.280
Why?
Cohort Studies
5
2023
1829
0.260
Why?
Health Status
2
2018
212
0.250
Why?
Administration, Oral
3
2016
100
0.250
Why?
Randomized Controlled Trials as Topic
5
2020
305
0.250
Why?
Societies, Medical
3
2023
146
0.250
Why?
Sex Distribution
3
2019
76
0.250
Why?
Palliative Care
2
2023
104
0.240
Why?
Antihypertensive Agents
2
2020
70
0.240
Why?
Hemorrhage
5
2020
75
0.240
Why?
Risk Adjustment
2
2021
10
0.230
Why?
Incidence
4
2020
714
0.230
Why?
Obesity
4
2020
277
0.230
Why?
Logistic Models
3
2021
362
0.230
Why?
Young Adult
3
2020
1853
0.230
Why?
Hospital Charges
2
2020
16
0.220
Why?
Leadership
2
2022
95
0.220
Why?
Illinois
2
2021
227
0.220
Why?
Cost-Benefit Analysis
2
2022
125
0.220
Why?
Age Distribution
2
2020
81
0.220
Why?
Minority Groups
1
2023
70
0.220
Why?
Insulin-Like Growth Factor I
1
2024
52
0.220
Why?
Cardiotoxicity
2
2020
8
0.220
Why?
Maternal Mortality
1
2023
6
0.210
Why?
Pulmonary Veins
1
2023
26
0.210
Why?
Health Promotion
2
2016
147
0.210
Why?
Morbidity
2
2019
55
0.210
Why?
Death
1
2023
47
0.210
Why?
Out-of-Hospital Cardiac Arrest
1
2022
8
0.200
Why?
Adolescent
2
2020
2064
0.200
Why?
Philippines
1
2022
4
0.200
Why?
Pregnant Women
1
2022
10
0.200
Why?
Pregnancy Outcome
1
2022
16
0.200
Why?
Cesarean Section
1
2022
28
0.200
Why?
Attitude
1
2022
30
0.200
Why?
Polypharmacy
1
2022
7
0.200
Why?
Vitamin K
1
2022
7
0.200
Why?
Sotalol
1
2021
1
0.200
Why?
Venous Thromboembolism
1
2022
34
0.200
Why?
Prospective Studies
3
2023
1663
0.200
Why?
Pandemics
2
2023
238
0.200
Why?
Coronary Circulation
2
2020
24
0.190
Why?
Cardiac Electrophysiology
1
2021
2
0.190
Why?
Troponin
1
2021
8
0.190
Why?
Telemedicine
1
2023
98
0.190
Why?
Shock, Cardiogenic
1
2021
5
0.190
Why?
Sexism
1
2021
7
0.190
Why?
Alcohol Drinking
1
2022
68
0.190
Why?
Diagnostic Techniques, Cardiovascular
1
2021
2
0.190
Why?
Hormones
1
2021
8
0.190
Why?
Water-Electrolyte Imbalance
1
2021
2
0.190
Why?
Death, Sudden, Cardiac
1
2021
14
0.190
Why?
Sleep Apnea, Obstructive
1
2022
54
0.190
Why?
Overweight
1
2022
67
0.190
Why?
Women's Rights
1
2021
2
0.180
Why?
National Institutes of Health (U.S.)
1
2021
23
0.180
Why?
Signal Processing, Computer-Assisted
2
1998
31
0.180
Why?
Angioplasty
1
2020
6
0.180
Why?
Peripheral Arterial Disease
1
2020
5
0.180
Why?
Weight Loss
1
2022
120
0.180
Why?
Physician-Patient Relations
1
2021
37
0.180
Why?
Health Expenditures
1
2020
18
0.180
Why?
Periodicals as Topic
1
2021
32
0.180
Why?
Disease Outbreaks
1
2021
77
0.180
Why?
Career Choice
1
2021
29
0.180
Why?
Heart Valve Diseases
1
2020
16
0.180
Why?
Hyperlipidemias
1
2020
14
0.180
Why?
Postoperative Hemorrhage
1
2020
21
0.180
Why?
Endovascular Procedures
1
2020
31
0.180
Why?
Myocardial Revascularization
1
2020
15
0.180
Why?
Accidental Falls
1
2022
113
0.180
Why?
Postnatal Care
1
2020
7
0.180
Why?
Delivery, Obstetric
1
2020
12
0.170
Why?
Heart Valve Prosthesis Implantation
1
2020
20
0.170
Why?
Radiation-Protective Agents
1
2020
3
0.170
Why?
Protective Factors
1
2020
21
0.170
Why?
Infant, Newborn
1
2022
596
0.170
Why?
Odds Ratio
2
2020
260
0.170
Why?
Colchicine
1
2020
10
0.170
Why?
Clinical Trials as Topic
1
2021
216
0.170
Why?
Prostatic Neoplasms
1
2021
89
0.170
Why?
Social Class
1
2020
64
0.170
Why?
Thrombolytic Therapy
1
2020
46
0.170
Why?
Income
1
2020
73
0.170
Why?
Radiation Injuries
1
2020
25
0.170
Why?
After-Hours Care
1
2019
1
0.170
Why?
Global Health
1
2019
37
0.170
Why?
Up-Regulation
2
2021
151
0.170
Why?
Cardiac Resynchronization Therapy
1
2019
12
0.170
Why?
Health Behavior
1
2020
153
0.160
Why?
Multimodal Imaging
1
2019
23
0.160
Why?
Heart
1
2019
56
0.160
Why?
Surveys and Questionnaires
3
2022
1066
0.160
Why?
Treatment Refusal
1
2018
11
0.160
Why?
Heart Transplantation
1
1998
24
0.160
Why?
Intensive Care Units
1
2021
279
0.160
Why?
Reproducibility of Results
3
2017
670
0.160
Why?
Asia, Western
1
2018
2
0.150
Why?
Indian Ocean Islands
1
2018
2
0.150
Why?
Procainamide
1
1998
1
0.150
Why?
Atrial Flutter
1
1998
4
0.150
Why?
Graft Rejection
1
1998
63
0.150
Why?
Tachycardia
2
2021
9
0.150
Why?
Walking
1
2020
257
0.150
Why?
Sulfonamides
1
1998
37
0.150
Why?
Diagnosis, Differential
1
2019
342
0.150
Why?
Inpatients
1
2019
132
0.150
Why?
Memory Disorders
1
2019
166
0.150
Why?
Coronary Disease
2
2020
51
0.150
Why?
Echocardiography
4
2023
79
0.140
Why?
Patient Discharge
1
2018
151
0.140
Why?
Diet Surveys
1
2017
19
0.140
Why?
Lupus Erythematosus, Systemic
1
2020
189
0.140
Why?
Evidence-Based Medicine
1
2018
186
0.140
Why?
Nutrition Assessment
1
2017
34
0.140
Why?
Neoplasms
1
2020
219
0.140
Why?
Evidence-Based Practice
1
2017
78
0.140
Why?
Rivaroxaban
1
2016
5
0.140
Why?
Dabigatran
1
2016
5
0.140
Why?
Thiazoles
1
2016
18
0.140
Why?
Pyridones
1
2016
10
0.140
Why?
Patient Selection
2
2020
193
0.140
Why?
Pyridines
1
2016
36
0.140
Why?
Dementia
1
2022
532
0.130
Why?
Sensitivity and Specificity
2
2015
485
0.130
Why?
Coronary Vessels
2
2021
31
0.130
Why?
Georgia
1
2016
10
0.130
Why?
Platelet Aggregation Inhibitors
1
2016
45
0.130
Why?
Cholesterol, LDL
1
2016
25
0.130
Why?
Self Efficacy
1
2016
55
0.130
Why?
Pyrazoles
1
2016
55
0.130
Why?
Health Surveys
1
2016
84
0.130
Why?
Chicago
2
2016
845
0.130
Why?
Diet, Mediterranean
1
2017
83
0.130
Why?
Equipment Design
2
2015
141
0.130
Why?
Miniaturization
1
2015
2
0.120
Why?
Preventive Health Services
1
2015
15
0.120
Why?
Heart Rate
2
2009
103
0.120
Why?
Equipment Failure Analysis
1
2015
100
0.120
Why?
Smoking
2
2018
169
0.110
Why?
Cardiac Pacing, Artificial
2
1992
22
0.110
Why?
Needs Assessment
1
2013
38
0.110
Why?
Drug Monitoring
1
2012
17
0.100
Why?
Heart Conduction System
1
1992
10
0.100
Why?
Activities of Daily Living
1
2016
523
0.100
Why?
Data Collection
1
2012
91
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
66
0.100
Why?
Registries
3
2022
171
0.100
Why?
Blood Pressure
2
2023
194
0.090
Why?
Motor Activity
1
2013
314
0.090
Why?
Coronary Artery Bypass
2
2020
23
0.080
Why?
Survival Rate
2
2019
321
0.080
Why?
Databases, Factual
2
2019
325
0.070
Why?
Severity of Illness Index
2
2021
930
0.070
Why?
Time Factors
3
2021
1364
0.070
Why?
Azetidines
1
2006
1
0.070
Why?
Benzylamines
1
2006
10
0.070
Why?
Body Mass Index
2
2020
412
0.070
Why?
Endpoint Determination
1
2004
20
0.060
Why?
Postoperative Complications
2
2020
862
0.060
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
3
0.060
Why?
Brain-Derived Neurotrophic Factor
1
2024
43
0.050
Why?
Pharmacists
1
2023
16
0.050
Why?
Follow-Up Studies
2
2019
1713
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2022
3
0.050
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
20
0.050
Why?
Double-Blind Method
2
2006
399
0.050
Why?
Flecainide
1
2021
1
0.050
Why?
Genetic Testing
1
2022
52
0.050
Why?
Delivery of Health Care
1
2023
145
0.050
Why?
Microcirculation
1
2021
27
0.050
Why?
Ischemia
1
2021
20
0.050
Why?
Diuretics
1
2021
6
0.050
Why?
Pregnancy, High-Risk
1
2021
2
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Chlorides
1
2021
25
0.050
Why?
Recurrence
2
2006
306
0.050
Why?
Sodium
1
2021
60
0.050
Why?
Health Services Research
1
2021
39
0.050
Why?
Hypercholesterolemia
1
2020
18
0.050
Why?
Patient Preference
1
2021
30
0.040
Why?
Education, Medical
1
2021
38
0.040
Why?
Case-Control Studies
2
2000
550
0.040
Why?
Lactation
1
2021
56
0.040
Why?
Fetal Growth Retardation
1
2020
2
0.040
Why?
Polycystic Ovary Syndrome
1
2020
2
0.040
Why?
Abortion, Spontaneous
1
2020
4
0.040
Why?
Menopause, Premature
1
2020
6
0.040
Why?
Clinical Decision-Making
1
2020
35
0.040
Why?
Sleep Apnea, Central
1
2000
29
0.040
Why?
Health Care Costs
1
2020
72
0.040
Why?
Attitude to Health
1
2020
92
0.040
Why?
Radiotherapy
1
2020
31
0.040
Why?
Curriculum
1
2021
141
0.040
Why?
Neuropsychological Tests
1
2024
1228
0.040
Why?
Autoimmune Diseases
1
2020
39
0.040
Why?
Costs and Cost Analysis
1
2019
34
0.040
Why?
Thrombectomy
1
2019
29
0.040
Why?
Multivariate Analysis
1
2020
295
0.040
Why?
Disease Management
1
2020
108
0.040
Why?
Cause of Death
1
2019
57
0.040
Why?
Health Services Needs and Demand
1
2018
44
0.040
Why?
Psychology
1
2018
21
0.040
Why?
Heredity
1
2018
6
0.040
Why?
Cancer Survivors
1
2018
12
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
173
0.040
Why?
Diet, Western
1
2017
10
0.030
Why?
Quality Improvement
1
2018
150
0.030
Why?
Breast Feeding
1
2018
162
0.030
Why?
Drug Therapy, Combination
1
2016
170
0.030
Why?
Waist Circumference
1
2015
31
0.030
Why?
Genetic Predisposition to Disease
1
2018
373
0.030
Why?
Risk
1
2016
199
0.030
Why?
Body Composition
1
2016
61
0.030
Why?
Body Weight
1
2016
121
0.030
Why?
Decision Making
1
2018
222
0.030
Why?
Patient Compliance
1
2016
145
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
1
0.030
Why?
Dextroamphetamine
1
1993
2
0.030
Why?
Hypotension, Orthostatic
1
1993
11
0.030
Why?
Syncope
1
1993
4
0.030
Why?
Efficiency
1
2013
14
0.030
Why?
Social Networking
1
2013
11
0.030
Why?
Albuterol
1
1993
13
0.030
Why?
Bradycardia
1
1993
22
0.030
Why?
Interviews as Topic
1
2013
123
0.030
Why?
Program Evaluation
1
2013
124
0.030
Why?
Tachycardia, Ventricular
1
1992
22
0.030
Why?
Animals
1
2020
3391
0.030
Why?
Cardiac Catheterization
1
1992
61
0.020
Why?
Asthma
1
1993
109
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2006
5
0.020
Why?
Estrogen Replacement Therapy
1
2006
18
0.020
Why?
Thromboembolism
1
2006
16
0.020
Why?
Chi-Square Distribution
1
2006
133
0.020
Why?
Proportional Hazards Models
1
2006
327
0.020
Why?
Combined Modality Therapy
1
2004
277
0.010
Why?
Electrocardiography, Ambulatory
1
2000
9
0.010
Why?
Bronchoscopy
1
2000
28
0.010
Why?
Tracheostomy
1
2000
23
0.010
Why?
Respiration
1
2000
32
0.010
Why?
Anesthesia
1
2000
31
0.010
Why?
Child
1
2000
1229
0.010
Why?
False Positive Reactions
1
1993
32
0.010
Why?
Contraindications
1
1993
32
0.010
Why?
Administration, Inhalation
1
1993
29
0.010
Why?
Action Potentials
1
1993
85
0.010
Why?
Posture
1
1993
63
0.010
Why?
ROC Curve
1
1992
132
0.010
Why?
Analysis of Variance
1
1992
253
0.010
Why?
Volgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (370)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_